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Abstract
Chronic respiratory diseases, in particular chronic obstructive pulmonary disease (COPD), can be classified as a part of the chronic 
diseases of lifestyle. A lifestyle intervention programme is therefore an essential component of the non-pharmacological management 
of COPD and other chronic respiratory diseases. The main indication for referral to a lifestyle intervention programme is any symp-
tomatic patient with either COPD or any other chronic respiratory disease, and who also has limited functional capacity. Following a 
comprehensive initial assessment, patients are recommended to attend either a group-based programme (medically supervised or 
medically directed, depending on the severity of the disease and the presence of any co-morbidities) or a home-based intervention 
programme. The main elements of the intervention programme are smoking cessation, exercise training (minimum of three times per 
week), education, psychosocial support and nutritional support. Regular monitoring should be conducted during training sessions, 
and a follow-up assessment is indicated after 2-3 months to assess progress and to re-set goals. Longer-term (56 months) interven-
tion programmes are associated with better long-term outcomes.
 This article has been peer reviewed. Full text available at www.safpj.co.za SA Fam Pract 2008;50(6):6-13
Introduction
Chronic respiratory disease is included in the list of chronic diseases of 
lifestyle because they represent diseases that are defined by common 
lifestyle associated risk factors such as smoking, physical inactivity, 
poor nutritional choices, obesity, and psychosocial factors.1 The link 
between these risk factors and the primary and secondary prevention 
of these chronic diseases has been reviewed in the first of a series of 
articles in this journal that focus on lifestyle interventions for chronic 
disease.1 It is important to note that there are a number of chronic 
respiratory diseases, but the most common disease group is chronic 
obstructive pulmonary disease (COPD). COPD is the leading cause of 
lung-related death and disability.2 The COPD disease group typically 
refers to chronic bronchitis and emphysema and is characterised by 
progressive airflow obstruction that is only partially reversible.2-4 It has 
been suggested, from a number of well-conducted studies, that the 
world-wide prevalence of COPD is 7–19%.5 This means that the total 
number of cases of COPD in the world is about 280 million persons. 
Of particular concern is also the fact that this is a disease that is 
increasing in women.5 In South Africa, chronic lung disease is also very 
common and there is a complex interaction between lifestyle factors (in 
particular smoking),6,7 social factors, nutritional factors and infectious 
diseases (notably tuberculosis, and HIV disease).8 
A detailed discussion of the epidemiology, pathogenesis, 
pathophysiology, diagnosis and pharmacological management of 
chronic lung disease, in particular COPD, has recently been reviewed, 
and is beyond the scope of this article.4 In this article, the third in 
the series, the emphasis is on the role of lifestyle change in the 
management of chronic respiratory disease (CRD), also known as 
pulmonary rehabilitation or the non-pharmacological management 
of CRD.9 For the purposes of this article, a lifestyle intervention 
programme for CRD and the term “pulmonary rehabilitation” will be 
used interchangeably. 
Pulmonary rehabilitation has been defined by the American Thoracic 
Society and the European Respiratory Society as “an evidence-
based, multidisciplinary, and comprehensive intervention for patients 
with chronic respiratory disease who are symptomatic and often 
have decreased daily life activities. Integrated into the individualised 
treatment of the patient, pulmonary rehabilitation is designed to reduce 
symptoms, optimise functional status, increase participation, and 
reduce health care costs through stabilising and reversing the systemic 
manifestations of the disease”.2 This form of lifestyle intervention for 
chronic respiratory disease therefore includes many elements including 
a patient assessment, exercise training, education, and psychosocial 
and nutritional support.2,10
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It is well established that pulmonary rehabilitation forms an integral part 
and is considered mandatory in the management of chronic obstructive 
pulmonary disease (COPD).2,4 However, it has been suggested 
that pulmonary rehabilitation is also an appropriate intervention for 
any stable patient with a chronic lung disease who is disabled by 
symptoms.2 Therefore, patients suffering from other chronic respiratory 
diseases (Table I) may also benefit from referral to a pulmonary 
rehabilitation programme.2,11 
Table I:  Chronic respiratory conditions other than COPD that may also respond 








Thoracic cage or chest wall abnormalities
Preparation for lung transplantation surgery
Preparation for lung resection surgery
In this article, the scientific rationale for a lifestyle intervention 
programme for CRD (pulmonary rehabilitation) will first be discussed. 
This will be followed by an outline of the elements incorporated in 
a typical pulmonary rehabilitation programme. Finally, the practical 
implementation of a lifestyle intervention programme for CRD will be 
reviewed. 
Rationale for a lifestyle intervention programme (pulmonary 
rehabilitation) for chronic respiratory disease (CRD)
The rationale and scientific basis for pulmonary rehabilitation has 
recently been reviewed and evidence-based clinical guidelines were 
published by the American College of Chest Physicians (ACCP) 
and the American Association of Cardiovascular and Pulmonary 
Rehabilitation (AACPR).2 The proven benefits of a lifestyle intervention 
programme (pulmonary rehabilitation) and the level of scientific 
evidence for each of these benefits are listed in Table II.2,11-13 
Table II:  Benefits of a lifestyle intervention programme (pulmonary 
rehabilitation) for chronic respiratory disease (CRD)
Level of scientific evidence Benefit of pulmonary rehabilitation
A – High level of evidence
Improving functional capacity (6-
minute walk or Shuttle walk test)
Improving the symptom of dyspnoea 
in patients with COPD
Improving health related quality of 
life in patients with COPD
B – Moderate level of evidence
Reducing the number of hospital 
days and other measures of health 
care utilisation
Psychosocial benefits for patients 
with COPD
C – Low or very low level of 
evidence
Cost efficacy of programmes for 
patients with COPD
Insufficient evidence to date Improving the survival of patients with COPD
Thus, there is strong scientific support for recommending a lifestyle 
intervention programme in chronic respiratory disease, notably for 
COPD. In particular, there is strong evidence that functional capacity 
increases, dyspnoea decreases and quality of life increases in patients 
undergoing such programmes. There is some evidence that these 
interventions reduce health care utilisation and improve psychosocial 
outcomes. Finally, it is important to note that systemic consequences 
of chronic respiratory disease (Table III)5 as well as co-morbidities such 
as cardiac disease, diabetes mellitus, hypertension, osteoporosis and 
psychological disorders are common in COPD patients (Table IV).14
Table III: Systemic consequences of chronic respiratory disease5
Decreased fat free mass
















The value of lifestyle intervention in the management of cardiac 
disease has already been addressed in Part II of this series.15 It is 
also well know that lifestyle interventions, including exercise training, 
are important components in the management of many of these 
co-morbidities. Therefore, apart from the direct benefits of a lifestyle 
intervention programme for patients with COPD and chronic lung 
disease (Table II), these intervention programmes also have an 
additional positive influence on the systemic consequences of chronic 
respiratory disease as well as existing co-morbidities. The role of 
lifestyle interventions in some of the other co-morbidities among COPD 
patients will be covered in future articles in this journal.
Elements of a lifestyle intervention programme (pulmonary 
rehabilitation) for chronic respiratory disease (CRD)
A comprehensive pulmonary rehabilitation programme can be defined 
as a programme of regular exercise training that also incorporates at 
least one, but typically a number of additional lifestyle elements such 
as smoking cessation, education, psychosocial support, nutritional 
counselling and intervention, and other novel components.2,16 It 
therefore stands to reason that a comprehensive lifestyle intervention 
programme for CRD can only be effectively administered by a multi-
disciplinary team of health professionals including general practitioners, 
sports and exercise medicine specialists (sports physicians), 
pulmonologists, biokineticists (applied exercise physiologists), 
nutritionists, psychologists, physiotherapists and others.11 
Patients are usually diagnosed and stabilised on optimum 
pharmacological treatment, after which they can be referred to a 
lifestyle intervention programme. The indications and contra-indications 
for referral of a patient to a lifestyle intervention programme for CRD 
are listed in Table V.
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Table V:  Indications and contra-indications for referral to a lifestyle intervention 
programme (pulmonary rehabilitation) for chronic respiratory disease 
(CRD)11,17
Indications
All patients with COPD and other 
CRD who have symptoms, and who 
have limited functional capacity 2,11,17
FEV1/FVC < 0.7 and FEV1 < 80% 
predicted post-bronchodilator 
(43}(18}5
BODE index > 3 * 5
Motivated patient
Adherent patient
Absolute contra-indications General contra-indications to exercise training and testing15
Sub-optimal pharmacological 
treatment of lung disease
Unstable or untreated co-
morbidities17
Severe-exercise induced 
hypoxaemia not correctable with 
oxygen supplementation
Inability to exercise due to severe 
lung or other disease (general 
contra-indications to exercise)
Severe cognitive dysfunction or 
psychiatric illness




* BODE index – functional index that predicts of outcome. This index 
is based on four functional measures including Body Mass Index 
(BMI), Obstruction (FEV1), Dyspnoea [modified Medical Research 
Council scale (MMRC)], Exercise tolerance (6 minute walk distance)18 
(Appendix A)
** Smoking cessation is a requirement by some health insurers before 
pulmonary rehabilitation services will be funded
A medical practitioner trained in sports and exercise medicine usually 
directs the programme and works with a team of health professionals 
to successfully administer all the elements of the programme. Close 
cooperation between the referring doctors and the multi-disciplinary 
team is strongly encouraged.
Practical implementation of a lifestyle intervention programme 
(pulmonary rehabilitation) for chronic respiratory disease (CRD)
The first step in the implementation of a pulmonary rehabilitation 
programme is a comprehensive initial assessment.11,17,19 This 
assessment should consist of a medical history, clinical examination 
and special investigations (as required). The aims of this assessment 
are:
• to confirm the indications for referral (Table V)
• to exclude contra-indications to the programme (Table V)
•  to identify any systemic consequences of chronic respiratory 
disease (Table III) and co-morbidities (Table IV) 
•  to determine functional capacity – this would typically include 
exercise electrocardiography (if indicated to exclude cardiac 
disease), 6-minute walk test, and tests to determine body 
composition, muscle strength, muscle endurance, and 
musculotendinous flexibility
• to confirm the severity/stage of the disease (Table VI)
• to determine nutritional status
•  to determine health status (quality of life), psychological well-being 
and social well-being (using instruments such as the Short Form-36 
and others)11
The determination of severity of chronic respiratory disease is an 
important component of the initial assessment. The severity of the 
disease process will to some extent determine the setting of a lifestyle 
intervention programme. There are two recommended methods of 
assessing severity (Table VI). These methods are mainly for COPD, 
but can be used for other chronic respiratory disease settings as they 
reflect functional impairment.
Table VI:  Assessment of the severity of COPD (and other chronic respiratory 









Mild FEV1 ≥ 80% predicted 0–2 Home based/self help#
Moderate FEV1 50–80% predicted 3–4 Medically directed#
Severe FEV1 30–50% predicted 5–6 Medically supervised
Very severe FEV1 ≤ 30% predicted 7–10 Medically supervised
* Global Initiative for Chronic Obstructive Lung Disease (GOLD), 
American Thoracic Society (ATS), European Respiratory Society (ERS)
** BODE index – functional index that predicts outcome. This index is 
based on four functional measures including Body Mass Index (BMI), 
Obstruction (FEV1), Dyspnoea [modified Medical Research Council 
scale (MMRC)] Exercise tolerance (6 minute walk distance) (Appendix 
A)18
# These recommendations apply only if no other indications for 
medically directed or medically supervised programmes are present 
such as the existence of co-morbidities (e.g. cardiac disease) which 
may place individuals at higher risk during exercise training 15 
Once a patient has been assessed, an individual lifestyle intervention 
programme can be planned. 
Education
An educational strategy is a key component of any lifestyle intervention 
programme for patients with chronic disease in general, including 
chronic respiratory disease.9,17,19,19 The general practitioner is uniquely 
positioned to address this first component of a lifestyle intervention 
programme for these patients.
The educational component can be delivered in a variety of ways 
including group sessions (typically weekly and just before or after an 
exercise session), or through information booklets/pamphlets, and 
individual counselling.11 This intervention should not only focus on 
improving knowledge but should primarily be aimed at teaching skills.17 
The content of an educational programme can vary but would normally 
include the following topics11,19:
• Causes and consequences of common lung diseases
• Medications that are commonly used to treat lung disease
• Oxygen therapy
• Principles of exercise training
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• Monitoring during exercise training
• Breathing techniques
• Dealing with depression, anxiety and stress
• Nutrition and lung disease
• Recognising acute exacerbations of lung disease
• What to do in emergencies
• Travelling with lung disease
• Coping with end-of-life issues 
The precise impact and value of an educational programme for 
patients with chronic respiratory disease has not been well studied.11 
However, the importance of an educational programme in chronic 
disease management is widely recognised and it should therefore be 
included.  
Smoking cessation
As smoking is the most important cause of COPD, smoking cessation 
is one of the most important and cost-effective means of 1) reducing 
COPD risk, and 2) preventing or delaying the development of airflow 
limitation.2,4,5,20 In South Africa, there is a considerable general burden 
of chronic disease that is attributable to smoking.6,7 In the context 
of lifestyle intervention programme for chronic respiratory disease, 
smoking cessation is therefore one of the most important lifestyle 
interventions,20 and in some instances, continued smoking has been 
considered a relative contra-indication to enrolment in pulmonary 
rehabilitation.11 
In any lifestyle intervention program, a smoking cessation educational 
and support programme must be included.20 In the first instance, the 
reasons that cause patients to continue smoking should be identified. 
These reasons are often multi-factorial and include the addictive 
potential of nicotine, conditional responses to stimuli surrounding 
smoking, depression, poor education low income, and forceful 
advertising campaigns.5
The elements of a successful smoking cessation programme should 
address these factors and include the following:
•  A strong message from the medical staff including the general 
practitioner to stop smoking4,19 
• Assessing readiness to stop smoking19
• Identifying both motivating factors and barriers to stopping19
• Acknowledging the difficulty in stopping19
•  Providing educational information that describes the specific 
benefits of stopping 9 
•  Use of self-help books, support groups, chat rooms.19 Examples of 
two self-help programmes in South Africa are:
 o Smokenders (http://www.smokenders.co.za)
 o  Allen Carr’s Easyway to stop smoking (http://
www.allencarr.co.za/)   
•  Pharmacological interventions can be considered and include 
the following: nicotine (dermal patch, gum, inhalers, nasal spray), 
slow release bupropion, varenicline (relieving nicotine withdrawal 
symptoms)4,5,19
•  Reducing and eliminating occupational and other exposures to 
airborne pollutants should also be addressed4
In addition to the benefits of smoking cessation in reducing the risk of 
other chronic diseases of lifestyle such as cardiovascular disease,15 
successful smoking cessation in patients with chronic respiratory 
disease is associated with preserved lung function, improved 
symptoms, and improved mortality.19 Smoking cessation should 
therefore be a key element in a lifestyle intervention programme for 
patients with chronic respiratory disease.  
Exercise training
It has been suggested that exercise training is, after smoking 
cessation, the cornerstone of a lifestyle intervention programme for 
chronic respiratory disease5,11,13 and should therefore be a mandatory 
component of such a lifestyle intervention programme.2,4 This 
recommendation is based on a high level of evidence (1A).2
 
The exercise training component of pulmonary rehabilitation can be 
administered in an in-patient setting, an out-patient setting or as a self 
administrated home-based programme.11 However, in most instances 
these programmes are administered in a group setting where sessions 
(usually 3/week) are supervised by members of the multidisciplinary 
lifestyle intervention team.11 
Setting and level of supervision of the exercise intervention
At present there are no precise guidelines on the risk stratification 
prior to exercise training for patients with chronic respiratory disease. 
Therefore, recommendations to determine the degree of medical 
supervision that is required during exercise rehabilitation sessions are 
not clear. However, there are criteria that can be used as guidelines 
to identify high risk individuals where direct medical supervision is 
required during exercise for patients with chronic respiratory disease 
that undergo lifestyle intervention.11 
Guidelines for a setting where exercise training sessions should be 
conducted under direct medical supervision (medical doctor present at 
the training sessions) are: 
• severe or very severe respiratory disease (Table VI)
•  presence of co-morbidities where medical supervision would 
normally be indicated (e.g. cardiac disease)15
• slow convalescence from an acute respiratory illness
•  patients that receive additional treatment modalities during training 
(including supplemental oxygen, inspiratory pressure support, 
inspiratory muscle training)16
In patients with moderate respiratory disease (FEV1 50–70%, BODE 
3–4), or those with co-morbidities where medically directed exercise is 
indicated, pulmonary rehabilitation should take place in a group setting 
under medical direction (no doctor is necessarily required be present at 
supervised training sessions).
In patients with mild chronic respiratory disease (Table VI) and with 
minimal or no co-morbidities, the exercise intervention programme can 
be self administered in a home-based setting.
Practical implementation of the exercise training component 
The practical implementation of any exercise training programme 
is usually discussed by describing the following practical aspects 
of a training program: frequency of the training sessions, durations 
of individual training sessions, length of the intervention program, 
intensity of training, modality (type) of exercise training, monitoring 
and progression of training and special considerations in the training 
programme. The practical recommendations for each aspect of an 
exercise training programme for chronic respiratory disease are 
summarised in Table VII.
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Table VII:  Recommendations for each component of the exercise training in 





• Start the programme with training 2–3 times per 
week
• Can increase the training sessions to ≥ 3 times 
per week
Duration of a 
training session11,17
• The endurance training component of the session 
should be 20–30 minutes
• Most exercise sessions are in total about 60 
minutes 
Length of the 
programme11,13,17
• Minimum of 20 sessions (usually three times per 
week)
• Most programmes are for 12 weeks (three 
months) initially – a minimum of six weeks is 
recommended)
• A long term commitment to maintain an exercise 
training programme is strongly recommended  
Intensity of 
training11,13,16,17,21
• The intensity of training is determined by the 
outcome of a symptom limited exercise test
• Higher intensity exercise (> 60% maximum 
capacity) produces greater physiological benefits, 
and should be encouraged
• Interval training (alternating higher and lower 
intensity exercise) can be used effectively
• Lower intensity exercise is effective for patients 
with more severe disease
Type (modality) of 
training)11,12,16,17,21,22
• Endurance type training (walking, jogging, 
cycling, rowing, stair climbing, Nordic ski trainer) 
has traditionally been the main type of exercise 
and should be included
• Muscle strength training and strength-endurance 
training have recently been shown to have 
specific benefits in  patients with muscle atrophy 
and weakness
• Strength training showed greater improvements 
in Health Related Quality of Life (HRQL) 
outcomes than endurance training
• A combination of upper and lower extremity 
training is encouraged 





• Regular monitoring of each patients during 
training session is important and can include: 
documenting respiratory and other symptoms 
as well as the dyspnoea index, recording resting 
and exercise heart rate and blood pressure, 
documenting Rating of Perceived Exertion (RPE) 
during exercise
• Progression of the exercise training programme 
should take place at regular intervals (bi-weekly) 
and can include duration of sessions, intensity of 
exercise training, altered type of training and later 
the frequency of training sessions per week can 
be increased to most days of the week
In addition to the general exercise training recommendations (Table 
VII), patients with chronic respiratory disease may also benefit from 
special modalities to assist exercise training programmes. A detailed 
discussion of each of these special modalities is beyond the scope of 
this article. However, the following special modalities can be included 
as part of exercise training for patients with CRD:
•  The use of special breathing techniques such as “pursed lip” 
breathing and diaphragmatic breathing can be added to the 
standard exercise training programme11
•  An additional inspiratory muscle training programme can be added 
to the standard exercise training programme for patients with 
inspiratory muscle weakness (maximal inspiratory mouth pressure 
< 60% predicted baseline value)16
•  Oxygen supplementation during exercise training for patients that 
are already on long-term oxygen therapy and those with exercise-
induced hypoxaemia9,16,17,23
•  Exercise training accompanied by non-invasive mechanical 
ventilation (NIMV) can be used in patients with severe or very 
severe disease16,17,23
•  Exercise while breathing low-density gas mixtures may reduce the 
work of breathing during training – this special modality is currently 
not recommended for general use in the rehabilitation setting16,17,23
•  Neuromuscular electrical stimulation has been listed as a novel 
additional training modality to improve skeletal muscle function in 
these patients16,23
• Biofeedback techniques may also be of value23
Psychosocial intervention
It is well recognised that psychological and social consequences 
are common in patients suffering from chronic respiratory disease,24 
yet these are often not recognised and therefore not treated.13 
Furthermore, chronic psychosocial stress may lead to maladaptive 
coping behaviours (such as smoking and physical inactivity) which 
themselves increase the risk of, or exacerbate, CRD. The prevalence 
of psychological disorders in these patients ranges from 30–58% 25 
with anxiety and depression being the two commonest disorders (a 
prevalence of depression in about 45% of patients).13,24 As for other 
chronic diseases, the subjective experience of patients with COPD 
may be significantly affected with respect to self-perception and 
self-efficacy as functionality – both at home and at work – declines.1 
The consequent psychological responses such as fear, anger, social 
withdrawal13 and loss of meaning are likely to diminish quality of life 
and negatively impact compliance with both pharmacological and 
non-pharmacological treatments, creating a therapeutic ‘vicious circle’. 
Cognitive dysfunction has also been reported in patients with COPD 
with moderate to severe hypoxaemia.25 Cognitive dysfunction includes 
abnormalities in perceptual-motor integration, abstract reasoning, 
attention to auditory stimuli, learning and memory, and language 
skills.25 
The general practitioner is well-positioned to both assess and intervene 
at this level, providing an opportunity to mirror and reflect on the 
patient’s emotional experience, offer hope for improvement (through 
active rehabilitation programs) and even teach basic self-regulatory 
skills, which may enhance coping capacity. A psychosocial intervention 
programme should therefore be included as part of a lifestyle 
intervention programme for these patients.2,24 Exercise training, along 
with education and a psychosocial support program,  reduces anxiety 
and depression in patients with chronic respiratory disease.3 Elements 
of such a psychosocial programme are: developing an adequate 
social support system,24 learning stress reduction techniques – such 
as biofeedback-based relaxation, breathing techniques, mindfulness 
and yoga, creating an environment for patients to express and reflect 
on their emotions, and addressing specific problems including sexual 
intimacy, and partner or spouse dependency. If significant psychiatric 
illness is identified, these patients should be referred for specialist 
professional care.13 
It is important to note that the literature on psychosocial interventions 
in chronic diseases is still emerging and lacks granularity with 
respect to the content and quality of such interventions. As such 
a reference to “breathing techniques” for example does not take 
into account the myriad of techniques available and compare their 
relative effectiveness; further research addressing these specific 
sub-dimensions of a rehabilitation programme still remains to be 
done. It is apparent, however, at least theoretically, that psychosocial 
interventions which acknowledge the development of self-awareness26 
as their foundation, irrespective of the content, are more likely to 
produce long-term and sustainable clinical benefits as patient’s 
recognise the value of self-management and adherence to treatment.
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Nutritional intervention
The most common nutritional consideration in patients with chronic 
respiratory disease is associated involuntary weight loss, and muscle 
wasting.10,13,27 It has been shown that, in these patients, weight loss 
and muscle wasting are associated with an increased risk of acute 
exacerbations, hospital admissions, and the need for mechanical 
ventilation.10 It has been observed that muscle wasting and weight loss 
affects about 33% of patients with chronic respiratory disease. 
Therefore, a nutritional assessment (including determination of BMI 
and lean body mass) and a carefully planned nutrition programme 
are essential components of the lifestyle intervention programme for 
patients with chronic respiratory disease.13,27 Improvements in exercise 
capacity as well as improved respiratory function have been associated 
with successful nutritional repletion in these patients.27 A low BMI (< 21) 
is considered as an indicator of more severe disease, and has been 
included in the BODE index of disease severity (Appendix A).
Caloric supplementation should be considered in patients with a BMI 
< 21, involuntary weight loss > 10% in the last six months, or > 5% 
weight loss in the last month.13 Strength training should be encouraged 
to improve muscle mass in these patients. The use of creatine 
supplementation16 and anabolic steroids have recently been suggested 
as a possible additional treatment modalities for the decreased muscle 
mass seen in these patients.13,16,27 Other nutritional interventions that 
may be of value in these patients are polyunsaturated fatty acids,16 
anti-oxidants,10,16 appetite enhancers,27 and ghrelin supplementation (a 
novel growth hormone releasing peptide).16
Repeat assessment, follow-up and retention
All patients undergoing chronic disease rehabilitation should be 
assessed regularly during training sessions.17,19 Prior to each exercise 
training session, it is suggested that the following parameters be 
assessed and recorded: symptoms of respiratory disease (MMRC 
dyspnoea index, cough, sputum production, wheesing), other 
symptoms (cardiac, infectious disease), oxygen saturation, resting 
heart rate and resting blood pressure. During the exercise training, the 
following should be recorded:  rating of perceived exertion, peak heart 
rate, peak blood pressure and oxygen saturation.
All the parameters that were recorded during the initial assessment 
before entering the programme should be repeated after a defined 
period of intervention (usually 2–3 months).17,19 A feedback session 
should be arranged with the patient where these results are reviewed. 
At this session goal setting can be conducted and the intervention 
programme can be continued. Based on the repeat assessment this 
may require continued medically supervised or medically directed 
exercise training, or the patients can be discharged to continue with a 
self administered (home based) intervention programme. 
There are some data to suggest that longer rehabilitation programmes 
(5–6 months) are associated with better longer-term adherence 
and better outcomes than shorter programmes (2–3 months).12,28 
All the patients with chronic respiratory disease should be re-
assessed regularly (at least once per year) as compliance with home 
maintenance programmes is relatively low.17 
Summary and conclusions
In this review, the scientific rationale, indications, and practical steps 
to implement a lifestyle intervention programme for CRD, in particular 
COPD, were discussed. There is strong scientific evidence (level 1A) 
that a lifestyle intervention programme is an essential component of 
the non-pharmacological management of COPD and other chronic 
respiratory diseases. The main indication for referral to a lifestyle 
intervention programme is any symptomatic patient with either COPD 
or any other chronic respiratory disease, and who also has limited 
functional capacity. Following a comprehensive initial assessment, 
patients are recommended to attend either a group-based programme 
(medically supervised or medically directed, depending on the severity 
of the disease and the presence of any co-morbidities) or a home-
based intervention programme. The main elements of the intervention 
programme are smoking cessation, exercise training (minimum of 
three times per week), education, psychosocial support, behavioural 
intervention and nutritional support. Regular monitoring should be 
conducted during training sessions, and a follow-up assessment is 
indicated after 2–3 months to assess progress and to re-set goals. 
Longer-term (5–6 months) intervention programmes are associated 
with better long-term outcomes.  
Appendix A: Calculation of the BODE index (0–12)
The BODE index is calculated by adding all the scores of the four 
variables (in the table below) 18
Variable 0 1 2 3
Body mass index 
(BMI)
≥ 21 ≤ 21
Obstruction: FEV1 (% 
of predicted) 
≥ 65 50–64 36–49 ≤ 35
Dyspnoea (MMRC 
scale) grade*
0–1 2 3 4
Endurance: 6 minute 






* Modified Medical Research Council (MMRC) dyspnoea scale (grade)29:
Grade 0:  Not troubled with breathlessness except with strenuous 
exercise
Grade 1:  Troubled by shortness of breath when hurrying on the level 
or walking up a slight hill
Grade 2:  Walks slower than people of the same age on the level 
because of breathlessness or has to stop for breath when 
walking at own pace on the level
Grade 3:  Stops for breath after walking about 100 meters or after a few 
minutes on the level
Grade 4:  Too breathless to leave the house or breathless when 
dressing or undressing  
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